COVID-19 Research
UCRI FUNDING FOR COVID-19 Research
UCRI has invested $6.4 million in research funding for COVID-19 research from May 2020 - January 2022. UCRI funded four projects through the Emergency COVID-19 Research Seed Funding Opportunity. The UC-National Laboratory Fees Research Program immediately made $500,000 available to UC campuses for urgent research needs and also funded a $3.9M award to improve pandemic preparedness and health equity. The Multicampus Research Programs & Initiatives funded a UC-wide virtual biospecimen network and a collaboration to study the biophysics of the SARS-CoV-2 virus.
Key UCRI-funded projects are listed below:
Improving pandemic preparedness and health equity through wastewater-based epidemiology
- Lead Principal Investigator: Kara Nelson, Ph.D., UC Berkeley
- Collaborating Sites: Davis, San Francisco, Lawrence Livermore
UC Coronavirus Assembly Research Consortium
- Lead Principal Investigator: Roya Zandi, Ph.D., UC Riverside
- Collaborating Sites: Davis, Merced
UC VIRTUAL BIOSPECIMEN NETWORK FOR COVID-19 CLINICALLY COLLECTED BIOSPECIMENS
- Lead Principal Investigator: Nick Anderson, Ph.D., UC Davis
- Collaborating Sites: Irvine, Los Angeles, San Diego, San Francisco
DO ACE INHIBITORS AND ARBs INFLUENCE SEVERE OUTCOMES IN COVID-19 INFECTION?
- Lead Principal Investigator: Lori Daniels, M.D., UC San Diego
- Collaborating Sites: Los Angeles, San Francisco
IMPACT OF COVID-19 ON JUSTICE INVOLVED YOUNG ADULTS: THE YOUNG ADULT COURT STUDY
- Lead Principal Investigator: Elizabeth Cauffman, Ph.D., UC Irvine
ROLE OF DENDRITIC CELLS AND MACROPHAGES IN INCREASED SUSCEPTIBILITY OF ELDERLY TO SARS-CoV2
- Lead Principal Investigator: Anshu Agrawal, Ph.D., UC Irvine
SEROSURVEILLANCE OF HEALTH CARE WORKERS FOR COVID-19 USING A CORONAVIRUS ANTIGEN MICROARRAY
- Lead Principal Investigator: Saahir Khan, M.D., UC Irvine